FDA Law Blog

JANUARY 6, 2022

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs’ pay structure was important to the Court’s decision regarding the EKRA issue.

Lab Testing 52

Lab Testing Referral Individual Patient-Centered 52

FDA Law Blog

JANUARY 6, 2022

In general, EKRA prohibits, knowingly and willfully, soliciting, receiving, paying or offering kickbacks in exchange for referring to, inducing a referral to, or using the services of a recovery home, clinical treatment facility, or laboratory. S&G Labs’ pay structure was important to the Court’s decision regarding the EKRA issue.

Lab Testing 40

Lab Testing Individual Referral Patient-Centered 40

Annals of Family Medicine

NOVEMBER 20, 2024

These disparities may be related to differences in access to recommended chronic disease management. Objective: To describe patterns of chronic disease management across rural, small urban, and metropolitan settings, and explore variation by coinciding treatment for mental illness.

Chronic Disease Management 130

Chronic Disease Management Chronic Disease Illness Management 130